Stay updated on Pembrolizumab + Paclitaxel in HR+ MBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Paclitaxel in HR+ MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Paclitaxel in HR+ MBC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page's revision metadata was updated from v3.6.5 to v3.6.6, indicating a newer version of the site template used to render the page.
    Difference
    0.1%
    Check dated 2026-09-01T19:17:34.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.5, replacing the previous v3.6.4. This indicates a small backend update with no changes to the trial information shown on the page.
    Difference
    0.1%
    Check dated 2026-08-11T17:14:08.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The footer now displays Revision: v3.6.4, replacing Revision: v3.6.3. This indicates a minor version update to the page, likely for maintenance.
    Difference
    0.1%
    Check dated 2026-07-28T10:58:26.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.3, replacing v3.6.0. This indicates a minor update to the page template or rendering without affecting the study details or user-visible information.
    Difference
    0.1%
    Check dated 2026-06-30T00:55:51.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    The study page adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and introduces a Last verified metadata label, while existing labels such as Verified, Last known status was:, Intervention / Treatment, and Revision have been removed or renamed. These changes reorganize the page's structure and metadata without modifying the underlying study information or eligibility criteria.
    Difference
    2%
    Check dated 2026-06-15T18:53:17.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.4 to v3.5.5 on the Study Record, reflecting a minor page update. No substantive study content or eligibility details appear to be changed.
    Difference
    0.1%
    Check dated 2026-06-08T15:18:52.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Paclitaxel in HR+ MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Paclitaxel in HR+ MBC Clinical Trial page.